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Detection of Five Common CFTR Mutations by RapidCycle Real-Time Amplification Refractory Mutation
System PCR, Eugene Dempsey,1 David E. Barton,2 and
Fergus Ryan1* (1 Department of Biological Sciences, Dublin
Institute of Technology, Dublin, Ireland; 2 National Centre
for Medical Genetics and Department of Paediatrics,
University College Dublin, Our Lady’s Hospital for Sick
Children, Crumlin, Dublin, Ireland; * address correspondence to this author at: Department of Biological Sciences,
Dublin Institute of Technology, Kevin St., Dublin 8, Ireland; e-mail fergus.x.ryan@dit.ie)
Cystic fibrosis is the most common autosomal recessive
disease in Caucasian populations and has a carrier frequency of 1 in 25 (1 ). The gene involved codes for the
cystic fibrosis transmembrane conductance regulator
(CFTR), a membrane-associated protein involved in ion
transport across the plasma membrane of epithelial cells.
To date more than 1000 mutations have been described in
this gene, and most are rare (2 ). By focusing on five
common mutations it is possible to detect the diseasecausing mutation in ⬃90% of Irish patients (3 ). The five
mutations [and the percentages of Irish (3 ) and worldwide (2 ) cases] are F508del (77.4%, 66.0%), G551D (7.1%,
1.6%), R117H (2.7%, 0.3%), 621⫹1 G⬎T (1.4%, 0.7%), and
G542X (0.5%, 2.4%). Four of these fall into the severe class
of mutations in which the mRNA is incorrectly spliced
(621⫹1 G⬎T), or in which the protein is not synthesized
(G542X) or is blocked during processing (F508del), or its
regulation is blocked (G551D).
Mutations in the CFTR gene can be detected by many
mutation-detection systems, including single-strand conformation polymorphism analysis (4 ), restriction fragment length polymorphism analysis, Amplification Refractory Mutation System (ARMS) PCR (5 ), and more
recently, real-time PCR systems using Sybr Green 1 (6 ) or
hybridization probes (7 ). Currently, for mutation detection using hybridization probes on the LightCycler system, the detector probe is designed to overlie the possible
site of the mutation. This can have drawbacks when
multiplexing in the same detection channel because peaks
can become merged, making genotyping of a sample
difficult.
This study aimed to improve the multiplexing capabilities of real-time PCR in its use for mutation detection. To
this end we used ARMS PCR primers to selectively
amplify the wild-type or mutant alleles in separate reactions. Subsequent detection of PCR products was carried
out with a common set of hybridization probes. The
advantage of this system is that it increases flexibility in
design of the hybridization probe, allowing probes with
precise melting temperatures (Tms) to be generated. In
this way melting curve peaks can be at a predetermined
Tm for a particular PCR product, which allows for
easier multiplexing of real-time PCR. Similar ARMSbased techniques have been developed for the ABI
Prism 7700 sequence detector from PE Applied Biosystems using TaqMan® probes (8 ). These protocols depend on the detection of an amplification curve and are
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limited to the detection of one mutation per color
channel. Our protocol detects melting curve peaks post
amplification and allows multiple mutations to be
detected per color channel.
Both control samples for protocol optimization and test
samples for the blinded study were obtained from the
National Centre for Medical Genetics, Our Lady’s Hospital for Sick Children (Crumlin, Dublin, Ireland). This
study has received ethical approval from the DIT ethical
review board (Project Ref. SF01/02).
Two multiplex PCR reactions were optimized by use of
previously published ARMS primers (5 ). The first reaction detects the G551D, R117H, and F508del mutations
(87.2% frequency in Ireland, 67.9% worldwide). The
F508del ARMS primers (CF-DFjN and CF-DFwM) are
specific for this mutation and are not influenced by the
benign I506V and F508C mutations. Because the CFDFwM primer is complementary to the sequence distal to
F508del, the presence of the I507del mutation is not
recognized (5 ).
The second reaction detects the 621⫹1 G⬎T and G542X
mutations (1.9% frequency in Ireland, 3.1% worldwide). A
PCR product should be formed in both the A and B ARMS
reactions regardless of the sample genotype.
Three sets of fluorescence resonance energy transfer
hybridization probes were designed to detect the 10
different ARMS PCR products. R117H and 621⫹1 G⬎T
ARMS products are detectable by the CF4ARMS-A (5⬘CCTTTTGTAGGAAGTCACCAAAGCAGTAC-F-3⬘) and
CF4ARMS-P (5⬘-LCRed640-GCCTCTCTTACTGGGAAGAATCA-P-3⬘) hybridization probes (F indicates a fluorescein, and P indicates phosphate). The F508del ARMS
products are detected by the CF10ARMS-A (5⬘-GCACAGTGGAAGAATTTCATTCTGTTCTCAG-F-3⬘)
and
CF10ARMS-P (5⬘-LCRed640-TTCCTTGGATTATGCCTP-3⬘) hybridization probes. The CF11ARMS-A (5⬘-TATGATTACATTAGAAGGAAGATGTGCCTTT-F-3⬘) and
CF11ARMS-P (5⬘-LCRed705-AATTCAGATTGAGCATACT-P-3⬘) hybridization probes detect both the G551D
and G542X ARMS products. The predicted Tms of the
detector probes were calculated by use of MeltCalc software (www.meltcalc.com) (9 ). All probes and primers
were synthesized by Proligo, France.
ARMS PCR was carried out on a LightCycler (Roche
Diagnostics). The total reaction volume was 10 L, containing 1 L of 10⫻ LightCycler DNA Master Hybridization enzyme mixture (Roche Diagnostics), 3 mM MgCl2,
0.1 M hybridization probes, and ARMS primers concentrations as outlined in Table 1. ARMS PCR and subsequent melting curve analysis were carried out as follows:
Initial denaturation was for 7.5 min at 95 °C followed
by 40 cycles of 95 °C for 1 s, 64 °C for 20 s, and 72 °C for
20 s. A touchdown PCR was carried out with the annealing temperature starting at 70 °C and decreasing to
64 °C at 1 °C/cycle. Fluorescence was measured at the
end of the annealing step. The PCR stage was followed
by a melting curve analysis (95 °C for 10 s, 40 °C for
30 s, and heating back up to 70 °C at 0.1 °C/s) with
continuous monitoring of fluorescence. The touchdown
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Table 1. Concentrations of CFTR ARMS primers for multiplex reactions.
ARMS primer name and sequence,a 5ⴕ–3ⴕ

Multiplex reaction

Primer concentration, ng/reaction

DF-C: ACTTCACTTCTAATGATGATTATGGGAGA
DF-j-N: TATCTATATTCATCATAGGAAACACCACA
DF-w-M: TATCTATATTCATCATAGGAAACACCATT
11-C: TAAAATCAGCAATGTTGTTTTTGACCT
GD-j-N: GCTAAAGAAATTCTTGCTCGTTGCC
GD-j-W: AGCTAAAGAAATTCTTGCTCGTTGCT
RH-C: CACATATGGTATGACCCTCTACATAAACTC
RH-d-N: CCTCTGCCTAGATAAATCGCGATAGAAC
RH-d-M: CCTCTGCCTAGATAAATCGCGATAGAAT
621-C: TCACATATGGTATGACCCTCTATATAAACT
621-j-N: TGCCATGGGGCCTGTGCAAGGAAGTATTCC
621-j-M: TGCCATGGGGCCTGTGCAAGGAAGTATTCC
11-C: TAAAATCAGCAATGTTGTTTTTGACCT
GX-e-N: ACTCAGTGTGATTCCACCTTCTAC
GX-e-M: CACTCAGTGTGATTCCACCTTCTCA

1A/B
1A
1B
1A/B
1B
1A
1A/B
1A
1B
2A/B
2A
2B
2A/B
2B
2A

100
100
100
150
150
150
120
120
120
200
200
200
40
40
40

a

ARMS primer sequences are from Ferrie et al. (5 ).

PCR conditions used allowed specific amplification of
wild-type or mutated sequences as detected by standard agarose electrophoresis and melting curve analysis.
During the melting curve analysis, a temperature will
be reached that causes the fluorescence resonance energy
transfer to decrease as the detector probe is disassociated
from its complementary sequence adjacent to the anchor
probe. The first derivative of the melting curve is determined, which allows the decrease in fluorescence to be
seen as a peak. When we used the MeltCalc software to
assist in appropriate detector probe design, the actual Tms
seen during a melting curve analysis were within 1–2 °C
of the predicted Tms for the three detector probes.
CF4ARMS-P, CF10ARMS-P, and CF11ARMS-P produced
Tm peaks during melting curve analysis of ⬃62, 51, and
55 °C, respectively. In the melting curve profile of a
representative sample shown in Fig. 1, the orientation of
melting curve peaks can be clearly seen.
Using the optimized protocol as outlined in the
methods, we blind-tested a panel of patient samples
containing combinations of the five mutations. All
patient samples were correctly identified and correlated with previous genotyping carried out by standard
techniques.
The main advantage of the LightCycler system is its
speed: the above protocols require ⬃ 45 min. Genotyping
on the LightCycler system with standard multiplex hybridization probes that overlie the mutation site can be
technically challenging and have some limitations. Even
with careful design of the hybridization probes, wild-type
and mutant alleles may not necessarily be differentiated
from each other (10 ). Our system allows hybridization
probes to bind to any region of the amplicon, therefore
providing scope for better probe design. The number of
mutations that can be detected in a single reaction is
dependent on the number of melting peaks that can be

clearly differentiated from each other (11 ). This usually
leads to development of multiplex reactions in which a
single mutation is detected in a color channel. Here we
have demonstrated a method that makes it quite possible
to detect more than one mutation in a single channel. By
use of the nearest-neighbor formula in the MeltCalc
software, detector probes can be carefully designed that

Fig. 1. Melting curve profile of a R117H/G551D compound heterozygote.
The F2 channel (top plot) detects both the wild-type and mutant F508del and
R117H ARMS products with their respective peaks seen at ⬃51 and 62 °C. The
F3 channel (bottom plot) detects the G551D ARMS products with a peak seen at
55 °C. Reactions A and B are set up as given in Table 1. The two peaks seen in
the F2 channel at 62 °C and in the F3 channel at 55 °C show that this patient is
a carrier for both mutations. A single peak at 51 °C in the F2 channel for the A
reaction shows that only the wild-type F508del ARMS primers have produced a
product for this sample. The agarose gel image also correlates with the melting
curve peaks.
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produce a peak within 1–2 °C of the predicted Tm. This
allows Tm peaks, which indicate the presence or absence
of a PCR product, to be strategically placed within the
typical melting curve range of 45–70 °C for hybridization
probes. Over this melting curve range we feel it should be
possible to clearly distinguish three peaks in a single
channel. This potentially makes it possible to multiplex
six mutations in two capillaries when both fluorescent
channels are used. This enhances the capabilities of the
LightCycler for mutation detection; similar strategies
could also be used for other real-time systems.
The results presented here demonstrate the ability to
carry out multiplex mutation detection by use of a combination of ARMS PCR and real-time detection. A laboratory currently using ARMS PCR in a diagnostic setting
can quite easily convert the standard ARMS PCR to a
real-time ARMS PCR. This could have a major advantage
in time savings and reduce the handling of potential
carcinogenic ethidium bromide.
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Improvement of Low-Density Microelectronic Array
Technology to Characterize 14 Mutations/SingleNucleotide Polymorphisms from Several Human Genes
on a Large Scale, Sabrina Frusconi,1†* Betti Giusti,2† Luciana
Rossi,2 Sara Bernabini,1 Filippo Poggi,2 Irene Giotti,1 Rosanna
Abbate,2 Guglielmina Pepe,2 and Francesca Torricelli1
(1 Unita’ Operativa Citogenetica e Genetica, Azienda Ospedaliera Careggi, Florence, Italy; 2 Dipartimento Area
Critica Medico Chirurgica, University of Florence, Florence, Italy; † these authors contributed equally to this
work; * address correspondence to this author at: Unita’
Operativa Citogenetica e Genetica, Azienda Ospedaliera
Careggi, Viale Morgagni 85, 50134 Florence, Italy; fax
39-055-4279686, e-mail genomica@ao-careggi.toscana.it)
Large-scale human genetic studies require new technologies to genotype several samples with relative ease, high
accuracy, and reasonable costs. Among the available
approaches, a microelectronic array technology has been
developed for DNA hybridization analysis of mutations/
single-nucleotide polymorphisms (SNPs) (1– 4 ). The microelectronic array system (NanoChip® Molecular Biology Workstation; Nanogen) produces a defined electric
field that allows charged molecules, such as nucleic acids,
to be transported to any test site, or pad, on the electronic
chip (NanoChip cartridge). Electronic-based molecule addressing can rapidly achieve a high concentration of
amplicons on each pad of the cartridge. Control of temperature allows use of an optimal thermal stringency to
characterize a SNP/mutation in all 100 pads of a cartridge
simultaneously (5, 6 ). A thin hydrogel permeation layer
overlies the pads; the presence of avidin or streptavidin
in this layer allows the binding of biotinylated PCR
products.
Although the technology is attractive, only a few protocols for its use have been published (7–11 ). We describe
the development, optimization, and validation of a highthroughput method for SNPs and mutations analysis that
allows performance of 1372 characterizations on each
chip.
We studied samples from 150 individuals for 14 SNPs/
mutations previously characterized by standard methods
(restriction analysis, automatic sequencing, and allelic
discrimination). Genomic DNA was isolated from peripheral blood by use of the FlexiGene DNA reagent set
(QIAGEN GmbH). We analyzed 14 DNA mutations/
SNPs for a total of 2100 characterizations (homozygous
wild type, n ⫽ 1367; heterozygous, n ⫽ 522; homozygous
mutant, n ⫽ 211). The 14 nucleotide substitutions were
SNPs/mutations involving the glycoprotein Ia (GpIa),
glycoprotein IIIa (GpIIIa), follicle-stimulating hormone
receptor (FSHR), hereditary hemochromatosis (HFE), and
␣1 chain of collagen type 6 (COL6A1) genes.
For each mutation/SNP we designed a set of probes
consisting of a forward and a reverse PCR oligonucleotide
(one oligonucleotide for each SNP/mutation was 5⬘biotinylated); two reporter oligonucleotides (one labeled
with Cy3, specific for the wild-type nucleotide; the other,
labeled with Cy5, specific for the mutant nucleotide), and

